Insa Schiffmann

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Journal: Neurology

Published: July 02, 2026

Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS).

Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS).

Journal: European journal of neurology

Published: August 12, 2025

Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD.

Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: August 02, 2024

Treatment of Cerebral Histiocytosis With Low Dose of Cobimetinib: A Report of 2 Cases.

Treatment of Cerebral Histiocytosis With Low Dose of Cobimetinib: A Report of 2 Cases.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 08, 2024

Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.

Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.

Journal: Health and quality of life outcomes

Published: March 22, 2023

Development and evaluation of evidence-based patient information handbooks about multiple sclerosis immunotherapies.

Development and evaluation of evidence-based patient information handbooks about multiple sclerosis immunotherapies.

Journal: Multiple sclerosis and related disorders

Published: February 11, 2022

Understanding Magnetic Resonance Imaging in Multiple Sclerosis (UMIMS): Development and Piloting of an Online Education Program About Magnetic Resonance Imaging for People With Multiple Sclerosis.

Understanding Magnetic Resonance Imaging in Multiple Sclerosis (UMIMS): Development and Piloting of an Online Education Program About Magnetic Resonance Imaging for People With Multiple Sclerosis.

Journal: Frontiers in neurology

Published: January 16, 2022

Long-term prognostic counselling in people with multiple sclerosis using an online analytical processing tool.

Long-term prognostic counselling in people with multiple sclerosis using an online analytical processing tool.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: October 26, 2020

Continence and Complication Rates of Artificial Urinary Sphincter Devices (AMS 800) for Parkinson and Stroke Patients with Incontinence after Prostate Surgery: Retrospective Analysis of a Prospective Database.

Continence and Complication Rates of Artificial Urinary Sphincter Devices (AMS 800) for Parkinson and Stroke Patients with Incontinence after Prostate Surgery: Retrospective Analysis of a Prospective Database.

Journal: Urologia internationalis

Published: August 19, 2020

Construction of a User-Led Resource for People Transitioning to Secondary Progressive Multiple Sclerosis: Results of an International Nominal Group Study.

Construction of a User-Led Resource for People Transitioning to Secondary Progressive Multiple Sclerosis: Results of an International Nominal Group Study.

Journal: Frontiers in neurology

Published: May 19, 2020

Assessing the effect of an evidence-based patient online educational tool for people with multiple sclerosis called UMIMS-understanding magnetic resonance imaging in multiple sclerosis: study protocol for a double-blind, randomized controlled trial.

Assessing the effect of an evidence-based patient online educational tool for people with multiple sclerosis called UMIMS-understanding magnetic resonance imaging in multiple sclerosis: study protocol for a double-blind, randomized controlled trial.

Journal: Trials

Published: January 26, 2020

Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy.

Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy.

Journal: PloS one

Published: October 07, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026